Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 34, No. 6, 2011
Issue release date: November 2011
Section title: Original Paper
Kidney Blood Press Res 2011;34:382–386

Varicella Zoster Infection in Renal Transplant Recipients: Prevalence, Complications and Outcome

Mustapic Z.a · Basic-Jukic N.a · Kes P.a · Lovcic V.a · Bubic-Filipi Lj.a · Mokos I.b · Kastelan Z.b · Zekan S.c
Departments of aNephrology, Arterial Hypertension and Dialysis, and bUrology, Clinical Hospital Centre Zagreb and School of Medicine, University of Zagreb, and cClinical Hospital for Infectious Diseases ‘Fran Mihaljevic’, Zagreb, Croatia
email Corresponding Author

Nikolina Basic-Jukic, MD, PhD

Department of Nephrology, Arterial Hypertension and Dialysis

Clinical Hospital Centre Zagreb

Kispaticeva 12, HR–10000 Zagreb (Croatia)

Tel. +385 1 2312 517, E-Mail nina_basic@net.hr


  1. Fishman JA: Infection in renal transplant recipients. Semin Nephrol 2007;27:445–461.
  2. Fehr T, Bossart W, Wahl C, Binswanger U: Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature. Transplantation 2002;73:608–611.
  3. Rodriguez-Moreno A, Sanchez-Fructuoso AI, Calvo N, Ridao N, Conesa J, Marques M, Prats D, Barrientos A: Varicella infection in adult renal allograft recipients: experience at one center. Transplant Proc 2006;38:2416–2418.
  4. Lauzurica R, Bayés B, Frías C, Fontseré N, Hernandez A, Matas L, Jimenez A, Bonet J, Romero R: Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil. Transplant Proc 2003;35:1758–1759.
  5. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK: Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 2004;4:108–115.
  6. Miller GG, Dummer JS: Herpes simplex and varicella zoster viruses: forgotten but not gone. Am J Transplant 2007;7:741–747.
  7. Arness T, Pedersen R, Dierkhising R, Kremers W, Patel R: Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis. Transpl Infect Dis 2008;10:260–268.
  8. Fishman JA: Infection in solid-organ transplant recipients. N Engl J Med 2007;57:2601–2614.
    External Resources
  9. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group: A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996;61:1029–1037.
  10. European Mycophenolate Mofetil Cooperative Study Group: Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995;345:1321–1325.
  11. Basic-Jukic N, Kes P, Bubic-Filipi LJ, Puretic Z, Brunetta B, Pasini J: Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation? Transplant Proc 2005;37:850–851.
  12. Basic-Jukic N, Racki S, Kes P, Mustapic Z: Cytomegalovirus infection in renal transplant recipients (in Croatian). Acta Med Croatica 2008;62:69–75.
    External Resources
  13. Marcén R: Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs 2009;69:2227–2243.
  14. Satoh S, Tada H, Murakami M, Tsuchiya N, Inoue T, Togashi H, Matsuura S, Hayase Y, Suzuki T, Habuchi T: The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation. Transplant Proc 2005;37:1751–1753.
  15. Rothwell WS, Gloor JM, Morgenstern BZ, Milliner DS: Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil. Transplantation 1999;68:158–161.
  16. Buell C, Koo J: Long-term safety of mycophenolate mofetil and cyclosporine: a review. J Drugs Dermatol 2008;7:741–748.
  17. Cox VC, Ensom MH: Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring? Ther Drug Monit 2003;25:137–157.
  18. Gnann JW: Other herpesviruses: herpes simplex virus, varicella-zoster virus, human herpes types 6,7 and 8; in Transplant Infections, ed 1. Philadelphia, Lippincott-Raven, 1998, pp 265–286.
  19. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA: Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009;8:731–740.
  20. Rogers SY, Irving W, Harris A, Russell NH: Visceral varicella zoster infection after bone marrow transplantation without skin involvement and the use of PCR for diagnosis. Bone Marrow Transplant 1995;15:805–807.
  21. Jantsch J, Schmidt B, Bardutzky J, Bogdan C, Eckardt KU, Raff U: Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation. Nephrol Dial Transplant 2011;26:365–368.
  22. Peterson LR, Ferguson RM: Fatal central nervous system infection with varicella- zoster virus in renal transplant recipients. Transplantation 1984;37:366–368.
  23. Herrero JI, Quiroga J, Sangro B, Pardo F, Rotellar F, Alvarez-Cienfuegos J, Prieto J: Herpes zoster after liver transplantation: incidence, risk factors, and complications. Liver Transpl 2004;10:1140–1143.
  24. Litjens NH, Huisman M, Baan CC, van Druningen CJ, Betjes MG: Hepatitis B vaccine-specific CD4+ T cells can be detected and characterised at the single cell level: limited usefulness of dendritic cells as signal enhancers. J Immunol Methods 2008;330:1–11.
  25. Crosnier J: Hepatitis B in haemodialysis: vaccination against HBS antigen. Proc Eur Dial Transplant Assoc 1981;18:231–240.